IGA VASCULITIS
Clinical trials for IGA VASCULITIS explained in plain language.
Never miss a new study
Get alerted when new IGA VASCULITIS trials appear
Sign up with your email to follow new studies for IGA VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare kidney diseases: sparsentan trial launches
Disease control Recruiting nowThis study tests an experimental drug called sparsentan in 67 children with certain kidney diseases that cause protein leakage in urine. The goal is to see if the drug is safe and can reduce protein levels over 108 weeks. Participants take the drug once daily as a liquid or table…
Matched conditions: IGA VASCULITIS
Phase: PHASE2 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
Skin biopsies shed light on rare blood vessel disease
Knowledge-focused Recruiting nowThis study looks at skin samples from 50 people with different types of vasculitis, a condition where blood vessels become inflamed. Researchers want to understand how the disease affects the skin at a molecular level. Participants must have an active skin rash related to their v…
Matched conditions: IGA VASCULITIS
Sponsor: Peter Merkel • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC
-
Pregnancy in vasculitis patients under the microscope
Knowledge-focused Recruiting nowThis study gathers information from women with vasculitis who become pregnant. Participants fill out online surveys about their disease and pregnancy experiences. The goal is to learn more about pregnancy outcomes in this group. No treatments or medications are tested.
Matched conditions: IGA VASCULITIS
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC